Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ISONASDAQ:NAUTNASDAQ:RPIDNASDAQ:SEER On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISOIsoPlexis$0.76$0.86$0.60▼$5.10$30.28M1.3268,375 shsN/ANAUTNautilus Biotechnology$0.71+1.1%$0.75$0.66▼$3.09$89.31M1.43128,106 shs625,153 shsRPIDRapid Micro Biosystems$3.13-9.8%$2.93$0.58▼$4.04$137.19M1.33194,663 shs189,709 shsSEERSeer$1.98+1.0%$2.03$1.56▼$2.63$116.56M1.54328,830 shs160,059 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISOIsoPlexis0.00%0.00%0.00%0.00%0.00%NAUTNautilus Biotechnology0.00%-0.80%-13.87%-28.48%-70.62%RPIDRapid Micro Biosystems0.00%-13.30%-1.88%+20.85%+306.49%SEERSeer0.00%-7.04%-5.26%+5.32%+18.56%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationISOIsoPlexisN/AN/AN/AN/AN/AN/AN/AN/ANAUTNautilus Biotechnology2.1183 of 5 stars3.02.00.00.00.64.20.6RPIDRapid Micro Biosystems1.928 of 5 stars2.04.00.00.02.62.50.6SEERSeer2.7352 of 5 stars3.03.00.00.02.53.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceISOIsoPlexis 0.00N/AN/AN/ANAUTNautilus Biotechnology 2.00Hold$2.13200.14% UpsideRPIDRapid Micro Biosystems 4.00Strong Buy$8.00155.59% UpsideSEERSeer 2.00Hold$3.0051.52% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookISOIsoPlexis$16.76M1.81N/AN/A$1.04 per share0.73NAUTNautilus BiotechnologyN/AN/AN/AN/A$1.66 per shareN/ARPIDRapid Micro Biosystems$29.65M4.63N/AN/A$1.75 per share1.79SEERSeer$14.17M8.23N/AN/A$5.54 per share0.36Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateISOIsoPlexis-$106M-$2.70N/AN/AN/A-632.41%-127.86%-71.41%N/ANAUTNautilus Biotechnology-$70.78M-$0.54N/AN/AN/AN/A-31.87%-27.39%7/29/2025 (Estimated)RPIDRapid Micro Biosystems-$46.89M-$1.03N/AN/AN/A-151.22%-56.07%-44.11%8/1/2025 (Estimated)SEERSeer-$86.60M-$1.41N/AN/AN/A-560.90%-24.69%-22.13%8/6/2025 (Estimated)Latest ISO, SEER, NAUT, and RPID EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025SEERSeer-$0.37-$0.34+$0.03-$0.34$3.25 million$4.21 million5/9/2025Q1 2025RPIDRapid Micro Biosystems-$0.27-$0.26+$0.01-$0.26$6.63 million$7.21 million4/29/2025Q1 2025NAUTNautilus Biotechnology-$0.14-$0.13+$0.01-$0.13N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthISOIsoPlexisN/AN/AN/AN/AN/ANAUTNautilus BiotechnologyN/AN/AN/AN/AN/ARPIDRapid Micro BiosystemsN/AN/AN/AN/AN/ASEERSeerN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioISOIsoPlexis1.124.062.50NAUTNautilus BiotechnologyN/A17.3617.36RPIDRapid Micro BiosystemsN/A4.613.23SEERSeerN/A19.3418.81Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipISOIsoPlexis44.91%NAUTNautilus Biotechnology50.71%RPIDRapid Micro Biosystems52.60%SEERSeer75.20%Insider OwnershipCompanyInsider OwnershipISOIsoPlexis6.40%NAUTNautilus Biotechnology41.10%RPIDRapid Micro Biosystems29.96%SEERSeer11.28%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableISOIsoPlexis45939.76 million37.22 millionNot OptionableNAUTNautilus Biotechnology130126.15 million74.30 millionOptionableRPIDRapid Micro Biosystems20043.83 million30.70 millionNot OptionableSEERSeer16058.87 million52.23 millionOptionableISO, SEER, NAUT, and RPID HeadlinesRecent News About These CompaniesKarnataka seer says free travel scheme raising mutts' visitors food burdenJune 19 at 10:27 AM | msn.comKarnataka Minister Backs Guarantees After Seer’s Remarks, Rules Out Longer Work Hours ClaimJune 19 at 5:27 AM | msn.comAP: Protect Vedas, save ancient tradition and culture: Udupi Sirur Mutt SeerJune 18 at 10:45 PM | uniindia.comBaba Vanga's chilling WW3 predictionJune 18 at 10:45 PM | msn.comBaba Vanga reveals: 4 zodiac signs will become extremely wealthy by the end of 2025June 18 at 5:45 PM | msn.comSiddaramaiah's guarantee schemes a burden on mutts: SeerJune 18 at 12:46 AM | msn.comCRC Outcomes Better When First of Multiple CancersJune 17 at 7:45 PM | medscape.comInsider Selling: Seer, Inc. (NASDAQ:SEER) Director Sells 30,253 Shares of StockJune 17 at 5:04 AM | insidertrades.comSeer, Inc. (NASDAQ:SEER) Director Dipchand Nishar Sells 30,253 SharesJune 16, 2025 | marketbeat.comWhere To Find The Seer In Tainted Grail: The Fall Of AvalonJune 13, 2025 | msn.comBright The Seer releases prophecy, sends powerful warning message to Tinubu, watch full videoJune 11, 2025 | msn.comRare cancer diagnoses surge dramatically among millennials, Gen XJune 11, 2025 | msn.comThe SEER Group Expands Northwest Presence With Acquisition of Oregon’s Associated Heating & Air ConditioningJune 10, 2025 | joplinglobe.comKalkine : Top NASDAQ Companies by Market Cap Featuring Seer IncJune 10, 2025 | kalkinemedia.comBright The Seer releases prophecy, reveals “anointed person to win 2027 presidential election”, watch full videoJune 10, 2025 | msn.comWhat Makes Seer, Inc. (SEER) a Strong Momentum Stock: Buy Now?June 10, 2025 | zacks.comSeer takes the lead in Miyawaki model forest developmentJune 10, 2025 | timesofindia.indiatimes.comVerydarkman slams Bright the Seer as she prophecies that Wizkid, Tinubu and Wike should see herJune 9, 2025 | msn.comAl Seer Marine's 'Lucky Gas' VLGC sets sailJune 8, 2025 | wam.aeSurgical Outcomes in OAs With Colorectal CancerJune 8, 2025 | physiciansweekly.comOtto Aviation: Unlocking Aerospace Innovation with Galoraths SEER PlatformJune 4, 2025 | eurekamagazine.co.ukNew MarketBeat Followers Over TimeMedia Sentiment Over TimeISO, SEER, NAUT, and RPID Company DescriptionsIsoPlexis NASDAQ:ISOIsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.Nautilus Biotechnology NASDAQ:NAUT$0.71 +0.01 (+1.06%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$0.71 0.00 (-0.14%) As of 06/18/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.Rapid Micro Biosystems NASDAQ:RPID$3.13 -0.34 (-9.80%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$3.15 +0.02 (+0.64%) As of 06/18/2025 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.Seer NASDAQ:SEER$1.98 +0.02 (+1.02%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$1.98 +0.01 (+0.25%) As of 06/18/2025 05:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Chime’s Smart IPO: Half the Valuation, Double the Strength 3 Tech Stocks With High and Rising Institutional Interest Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
